The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events

NCT00510731 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2015-12-09

No results posted yet for this study

Summary

This is a prospective study to evaluating the ability of the PD2i Cardiac Analyzer to predict the risk of serious heart rhythm abnormalities in high-risk patients that do not already have an Implantable Cardioverter Defibrillator.

Conditions

  • Tachycardia, Ventricular
  • Cardiac Sudden Death

Sponsors & Collaborators

  • Vicor Technologies, Inc.

    lead INDUSTRY

Principal Investigators

  • Matthew Reynolds, MD · VA Boston Healthcare System

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-11-30
Primary Completion
2009-12-31
Completion
2009-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00510731 on ClinicalTrials.gov